Moderna Continues to Be the Most Shorted S&P 500 Healthcare Stock in September
Moderna Is Maintained at Hold by Jefferies
Unveiling 18 Analyst Insights On Moderna
Moderna Analyst Ratings
GSK Files Patent Infringement Case Against Moderna
glaxosmithkline sues Moderna for infringing its patent rights on the COVID-19 vaccine.
GlaxoSmithKline October 15th | GlaxoSmithKline filed a lawsuit against Moderna in the Federal Court of Delaware on Tuesday, alleging that Moderna's COVID-19 vaccine Spikevax infringed on its patents in mRNA technology. The company filed a similar lawsuit against Pfizer and biontech in the same court in April this year.